Cantor Fitzgerald Recaps Aurora Cannabis' Q2 Report: 'Trends Are Encouraging'

Investors should continue sticking to the sidelines when it comes to Aurora Inc (NYSE: ACB).

That's according to a Cantor Fitzgerald analyst, citing the sales and EBITDA miss in the cannabis company's most recent earnings report.

The Aurora Cannabis Analyst: Cantor analyst Pablo Zuanic maintains a Neutral rating on Aurora's TSX-listed stock with a price target lifted from C$17 to C$18.

The Aurora Cannabis Thesis: Aurora reported total net cannabis sales of C$67.7 million that were 2% shy …

Full story available on Benzinga.com

More Cantor Fitzgerald Recaps Aurora Cannabis' Q2 Report: 'Trends Are Encouraging'